Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05702021 · ClinicalTrials.gov registry record · NA
Implementing Contingency Management for Stimulant Use in Specialty Addiction Treatment Organizations
A NA study of Stimulant Use (Diagnosis), sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 76
- Enrollment target
- 10
- Study locations
NCT05702021: Recruiting NA study of Stimulant Use (Diagnosis), sponsored by Northwestern University.
NCT05702021 is a NA study of Stimulant Use (Diagnosis) that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 76 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 10 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05702021, a NA study of Stimulant Use (Diagnosis), is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
- 10
- Study locations
Study Summary
Stimulants constitute a new and deadly fourth wave of the opioid epidemic. Contingency management is the most effective intervention for stimulant use and is an evidence-based adjunct to medication for opioid use disorder. Yet, uptake of contingency management in opioid treatment programs that provide medication for opioid use disorder remains low; in fact, access to contingency management is arguably one of the greatest research-to-practice gaps in the addiction treatment services field. The goal of this study is to conduct a type III hybrid effectiveness-implementation trial to evaluate a multi-level implementation strategy, the Science of Service Laboratory, to install contingency management for stimulant use in opioid treatment programs. The Science of Service Laboratory has three core components: didactic training, performance feedback, and external facilitation. Utilizing a stepped wedge design, a regional cohort of 10 public sector opioid treatment programs will be randomized to receive Science of Service Laboratory at five distinct time points. At six intervals, each of the 10 opioid treatment programs will provide de-identified electronic medical record data from all available patient charts on contingency management delivery and patient outcomes. Staff from each opioid treatment program will provide feedback on contextual determinants influencing implementation. This study will rigorously evaluate whether a multi-level implementation strategy developed by one of the longest-standing national intermediary purveyor organizations-the SAMHSA Technology Transfer Centers, will improve both implementation and patient outcomes.
Primary Outcome
This is an implementation outcome capturing Reach and is extracted from electronic medical records. This is a patient-level measure of the change in the percent of newly inducted patients with a history of stimulant use who are documented as having received 1 or more contingency management sessions from pre-implementation to post-implementation.
Conditions Studied
Interventions
- BEHAVIORAL Science to Service Laboratory
Study Locations (10)
Rhode Island
- Addiction Recovery Institute - Pawtucket
- CODAC Pawtucket - Pawtucket
- Providence Comprehensive Treatment Center - Providence
- VICTA - Providence
- CODAC Providence - Providence
- Woonsocket Comprehensive Treatment Center - Woonsocket
Illinois
- Lawndale Christian Health Center - Chicago
- Healthcare Alternative Systems NEXA-MAR - Chicago
- Community Outreach Intervention Projects Southside Mobile Van - Chicago
- Family Guidance Centers Chicago Ave. - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2023-06-07 |
| Est. Completion | 2027-08-01 |
| Phase | NA |
What NCT05702021 shows while recruiting
NCT05702021 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Stimulant Use (Diagnosis) appearing as the primary indexed condition, and to 1 intervention - of which Science to Service Laboratory is the first listed.
NCT05702021 lists 10 locations in 2 states (Rhode Island, Illinois).
Frequently Asked Questions
What is clinical trial NCT05702021 about?
NCT05702021 is a clinical study titled "Implementing Contingency Management for Stimulant Use in Specialty Addiction Treatment Organizations". Stimulants constitute a new and deadly fourth wave of the opioid epidemic. Contingency management is the most effective intervention for stimulant use and is an evidence-based adjunct to medication for opioid use disorder. Yet, uptake of contingency management in opioid treatment programs that provi...
What is the current status of trial NCT05702021?
This trial is currently recruiting. It is a NA study. The enrollment target is 76 participants. The study started on 2023-06-07. Estimated completion is 2027-08-01.
What conditions does trial NCT05702021 study?
This clinical trial studies the following conditions: Stimulant Use (Diagnosis).
What interventions are being tested in trial NCT05702021?
The interventions under investigation include: Science to Service Laboratory (BEHAVIORAL).
Who is sponsoring clinical trial NCT05702021?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05702021 being conducted?
This trial has 10 study locations across Illinois, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stimulant Use (Diagnosis)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05702021's enrollment target sits among peer trials
76 1063rd of 2000 higher than 932 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI